AskBio Inc. is a fully integrated gene therapy company and wholly owned subsidiary of Bayer AG dedicated to developing life-saving medicines for patients with rare and common diseases. The company maintains a clinical-stage pipeline targeting neuromuscular, central nervous system, cardiovascular, and metabolic disease indications, with investigational therapeutics for congestive heart failure, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson's disease, and Pompe disease. AskBio's proprietary gene therapy platform features Pro10™, an industry-leading cell line manufacturing process, along with hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. The company is pioneering science to create transformative molecular medicines while driving clinical outcomes to transform people's lives.
Beta · Sourced from candidate reports
Be the first to share your experience with AskBio Asklepios BioPharmaceutical, Inc..
Your reply helps other candidates know what to expect.
